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INTRODUCTION
Myocardial infarction is the term used when the myocardium is necrosed 
due to ischemia.  It may be transmural or subendocardial.
Patients with ischaemic heart disease fall into two large groups.  Patients 
with stable angina and patients with acute coronary syndromes (ACS).  ACS 
group in turn is composed of patients with acute myocardial infarction with ST 
elevation  (STEMI),  those  with  unstable  angina  (UA)  and  non  ST  segment 
elevation MI (NSTEMI).  
STEMI in elderly deserves special attention.  The highest risk group of 
patients with acute STEMI are clearly the elderly.  Cardiovascular death is the 
leading cause of death in elderly.  
Presentation of acute MI in elderly differs.  Even though the chest pain is 
the  most  common  symptom reported,  they  tend  to  present  more  often  with 
dyspnoea,  diaphoresis,  dizziness  and  syncope.   They  tend  to  present  to  the 
hospital a little later.  
Elderly tend to have more severe CAD and exhibit more complications 
and death.  It is recommended that the reperfusion therapy should be used more 
aggressively.  Management is often challenging because of the co-morbidities.
AIM OF THE STUDY
     To study the clinical profile of 60 cases of STEMI in elderly   
    (Age  65  and  above)  and  to  analyse  age  and  sex 
distribution, 
 symptomatology, clinical features, complications and 
outcome.
REVIEW OF LITERATURE
INTRODUCTION
The diagnosis and management of ischemic heart disease in the elderly is 
an  increasingly  frequent  challenge.  The  elderly  constitute  the  most  rapidly 
growing segment of our society.  They represent a  much larger proportion of 
patients with cardiac disease being treated in a hospital or in a physician’s office.
            In the elderly, ischemic disease itself is responsible for over one-half of 
the deaths and the vast majority of patients with congestive heart failure and 
cardiac disability. 
PHYSIOLOGICAL  CHANGES  ASSOCIATED  WITH  CARDIAC 
AGING
Age-related changes in cardiac function and structure are well described 
in normal man, and the mechanisms responsible for these are explored in animal 
models of aging.
The most important of these are prolonged contraction and relaxation and 
a diminished response to ß-adrenergic sympathetic stimulation.
Prolonged relaxation  is  evidenced by a  decrease  in  the  slope of  early 
mitral  valve closure on M-mode echocardiography, a decrease in peak filling 
rate and an increase in the time to peak filling rate on radionuclide angiography 
studies,  and  an  increase  in  Doppler  indices  of  atrial  contribution  to  left 
ventricular filling.
Prolonged  contraction  and  delayed  relaxation  properties  may  also  be 
related to  changes  in  physical  conditioning status  and endocrine function,  as 
exercise protocols and administration of thyroid hormone reverse some of these 
age-related changes.
In addition to changes in relaxation parameters, both animals and human 
data indicate that aging decreases cardiovascular ß-adrenergic responsiveness. 
This is true for the inotropic, chronotropic, as well as the vasodilating effects of 
these  agents.  Diminished  ß-adrenergic  responsiveness  results  in  a  decreased 
dependence  on  sympathetic-mediated  increases  in  heart  rate  and contractility 
during exercise stress, and a greater dependence on an increase in stroke volume 
mediated via an increase in end-diastolic volume-the frank-starling effect.
These changes may alter presenting symptoms in patients with ischemic 
disease. Ischemia, similar to aging, alters diastolic properties so as to increase 
end diastolic pressure for any given volume. Older individuals may therefore be 
more likely than younger patients to experience dyspnoeic symptoms for any 
given ischemic  or  tachycardic  insult.  Decreased  dependence  on  sympathetic-
induced cardiovascular changes to mediate an exercise response suggests that ß-
adrenergic blockers may be less effective anti-ischemic agents during exercise in 
older population.
RISK FACTORS
The risk factors in elderly include
 hypertension (specially isolated systolic hypertension)
 diabetes
 smoking
 hyperlipidemia
 physical inactivity
 others (obesity...)
IMPORTANCE OF RISK FACTORS
Although the significance of risk factors for the development of coronary 
disease  is  well  recognized  in  the  younger  and  middle-aged  groups,  the 
importance of risk factor management in the elderly is sometimes debated. 
HYPERTENSION
Epidemiological data indicate that systolic blood pressure is an important 
discriminator of cardiovascular risk for middle-aged and older men and women. 
In  addition,  several  studies  indicate  that  treating  diastolic  hypertension  in 
individuals in to the eighth decade of life reduces all cause mortality as well as 
cardiac and stroke mortality and morbidity. 
In  the  Systolic  Hypertension  in  Elderly  program  trial,  treatment  of 
isolated systolic hypertension(systolic, 160 mmhg or more) in those 60 yrs of 
age or  more resulted in  a  36% decrease  in  fatal  and nonfatal  stroke,  a  27% 
decrease  in  nonfatal  myocardial  infarction  or  coronary  death  and  a  32% 
reduction in all major cardiovascular events.
The  goals  of  antihypertensive  therapy  encompass  lowering  overall 
cardiovascular risk as well as decreasing the blood pressure.
Since  antihypertensive  therapy  impact  on  other  cardiovascular  risk 
factors, as well as concomitant diseases that older individuals are more likely to 
have, the influence of agents on these variables should also be considered. Thus, 
potassium-sparing diuretics may have favourable effect on electrolyte balance; 
ß-blockers and calcium blockers have anti-ischemic effects; ß-blockers provide 
secondary prevention post infarction; and ACE inhibitors slow the progression 
of renal disease in diabetic hypertensive patients, and improve outcomes in post 
infarction patients with left ventricular dysfunction. Finally, it is recognized that 
left ventricular hypertrophy is an independent risk factor for the development of 
coronary disease in elderly men and women.
The diagnosis and appropriate treatment of hypertension is an important 
goal in the prevention of coronary outcomes in older patients.
SMOKING
Another important remedial risk factor in the elderly is cigarette use. The 
effects of smoking cessation were evaluated in a subset of participants in the 
CASS registry. The relative risk of myocardial infarction or death over a 6-yr 
period for those who continued to smoke, as compared to those who stopped, 
was  2.9(1.4,5.9)for  those  men  and  women  70  yrs  of  age  and  older  and 
1.5(1.0,2.3)for those aged 65-69 yrs.  These were similar to or greater than the 
benefit in those under 65 yrs of age.
Thus, there is strong suggestive evidence that even our older patients can 
reduce cardiac risk when they stop smoking.
HYPERLIPIDEMIA
A common risk factor in older individuals is elevated lipids. Although 
earlier  data  were  conflicting,  recent  information  indicates  that  lipids-in 
particular, the HDL level is related to coronary mortality in older individuals.
In the Established Populations for Epidemiological Studies of the Elderly 
report, there was a 17% increase in the risk for coronary heart disease, death for 
every 1U increase in the total cholesterol/HDL cholesterol ratio in nearly 5000 
men  and  women  aged  71  yrs  or  older.HDL  cholesterol  was  also  related  to 
coronary outcomes in women and in those over 80 yrs of age. Although there are 
no data concerning the value of lipid lowering therapy for primary prevention in 
older population, there are data regarding its effectiveness in older individuals 
with known coronary disease.
In the Scandinavian study, HMG COA reductase inhibitor therapy was 
associated with a 0.73 relative risk of all cause mortality and a 0.71 relative risk 
of  a  major  coronary  event,  defined  as  coronary  death,  nonfatal  myocardial 
infarction, or cardiac arrest in those 60 yrs of age or more.
OTHER RISK FACTORS
There are other risk factors that are associated with coronary disease and 
mortality, although no prospective, randomized trials yet indicate that changing 
these factors changes cardiovascular outcomes in older population.
Obesity  is  one;  in  a  study  of  over  41,000  older  women,  body  fat 
distribution indexed by waist: hip ratio was associated with a strong, monotonic 
increase in the risk of cardiovascular, cancer,    and total mortality. The waist: 
hip ratio is also the best marker for the metabolic hazards of obesity including 
insulin resistance, hypertension, and hyperlipidemia.
As age increases, the ratio of women to men in the patient population 
with  ischemic  heart  disease  also  increases.  Postmenopausal  oestrogen  use  is 
associated  with  a  decrease  in  the  development  of  coronary  disease  and 
cardiovascular  mortality,  and  of  angiographic  evidence  of  coronary 
atherosclerosis. These benefits may be related to a rise in HDL levels, inhibition 
of  endothelial  proliferation,  and  a  favourable  influence  on  coronary 
vasoreactivity.
Other factors associated with decreased cardiovascular outcomes in older 
individuals  are  physical  activity  status,  dietary  antioxidant  flavonoid  intake, 
plasma fibrinogen and factor VII activity, and dietary, although not supplemental 
vitamin E intake.
DIAGNOSIS AND EVALUATION OF SEVERITY
The  diagnosis  of  coronary  disease  in  an  older  individual  should  be 
considered  with  the  realization  that  although  silent  ischemia  is  undoubtedly 
present in individuals of all age groups, it is particularly likely in the aged.
Baltimore  Longitudinal  Study  of  Aging  population  observed  the 
prevalence  of  exercise-induced  silent  ischemia,  defined  by  both 
electrocardiographic and thallium scintigraphic criteria,  increased from 2% in 
fifth decade to 15% in the ninth decade of life.
The  high  prevalence  of  silent  ischemia  may  be  due  to  a  diminished 
sensation  of  chest  discomfort,  the  increased  likelihood  that  ischemia  will 
manifest as dyspnea rather than more typical pain symptoms, and the fact that 
other,  superimposed  diseases  may  render  the  older  individuals  less  likely  to 
exercise to the point at which angina symptoms occur.
It is important, therefore, to go beyond just a negative history if a degree 
of certainty is required regarding the absence of ischemic disease in the elderly.
EXERCISE ELECTROCARDIOGRAM
The most useful objective test is the exercise electrocardiogram. But the 
predictive accuracy of a positive test is low in the setting of an abnormal ECG. 
This is more likely in older individuals because of the increased prevalence of 
left bundle branch block, left ventricular hypertrophy, and digitalis ingestion.
In these circumstances, an exercise isotope examination would be useful. 
It  should be noted that the predictive accuracy of a negative test is low in a 
population with a high prevalence of the disease.
Another  concern  in  older  population  is  an  inability,  because  of  other 
medical problems such as arthritis, or pulmonary insufficiency, to exercise to 85-
90% of the predicted maximum heart rate. In this setting, the predictive accuracy 
of  a  negative  test  is  low,  and  pharmacological  testing  with  dipyridamol, 
adenosine, or dobutamine in conjunction with electrocardiographic, isotope, or 
echocardiographic monitoring is useful.
Prognosis  in  patients  with  stable  coronary  disease  is  dependent  upon 
coronary  anatomy  and  left  ventricular  function.  Although  the  severity  of 
symptoms is one means of evaluating the severity of atherosclerosis, the absence 
or  presence  of  only  minimal  symptoms,  particularly  in  the  older  age groups 
cannot be relied upon to indicate the presence of only minimal disease. In this 
situation, the non invasive stress ECG is useful, not only in diagnosing disease, 
but also in assessing the likelihood of triple vessel or left main coronary stenosis. 
Indicators of severe disease, even in asymptomatic or minimally symptomatic 
patients, include an early positive test, one that remains positive for more than 8 
mins after the termination of exercise; more than 2 mm of ST segment shift; 
changes in the anterior and inferior leads with stress; a systolic fall in BP of 
more than 10-20 mmhg; and exercise induced malignant ventricular arrhythmias.
TREATMENT
It is often useful to consider whether noncardiac factors are present in an 
older  individual  who presents  with  new onset  angina  or  a  change  in  angina 
pattern. Anaemia frequently presents with ischemic symptoms in this age group. 
Hyperthyroidism in elderly often presents with cardiac manifestations, including 
arrhythmias  and  ischemia.  Supraventricular  arrhythmias,  hypertension,  and 
congestive  heart  failure  are  all  more  common  in  the  elderly  and  increase 
myocardial  oxygen  demand  requirements  as  well  as  decrease  supply. 
Identification and reversal of these precipitating factors therefore, may return the 
older individual to the asymptomatic status.
MEDICAL THERAPY
Sublingual nitrates are the most effective agents for the relief of an acute 
ischemic  episode.  Continuous  nitrates  alone  are  not  capable  of  providing 
continuous prophylaxis because of tolerance, which is present for oral, topical, 
as well as continuous intravenous use.  Tolerance is not present for β-blockers 
and calcium antagonists, and both classes are effective anti-ischemic agents.
The  choice  of  an  anti-ischemic  ß-blocker  can  be  based  on  associated 
medical  conditions  and  patient  convenience.  These  can  be  used  to  decide 
whether to use a hydrophilic or lipophilic agent,  as well as whether to use a 
cardio selective agent.
Calcium  antagonists  may  provide  additional  benefit  in  patients  who 
continue  to  experience  angina  despite  ß-blocker  therapy.  Some  calcium 
antagonists have antihypertensive, as well as anti-ischemic properties and are 
therefore especially useful in those angina patients with associated hypertension.
CORONARY ANGIOPLASTY
Angioplasty is an increasingly attractive option in elderly individuals with 
continued symptoms despite medical therapy. This is particularly true in those 
who are at increased risk with bypass surgery because it avoids thoracotomy, 
general anaesthesia, and prolonged convalescence associated with surgery. The 
development of newer techniques and increased experience in the treatment of 
multivessel  disease  has  increased  the  number  of  elderly  who  are  likely  to 
experience significantly improved symptoms with angioplasty. In a recent report 
of  768 patients  65 yrs  of  age or  more undergoing angioplasty,  the  technical 
success rate was 93.5%, in-hospital death rate was 1.4%; and 6-month death or 
myocardial infarction rate was 7.1%.
The International  Society and  Federation of  Cardiology and the World 
Health  Organization  Task  Force  on  Coronary   Angioplasty  lists  angina  in 
patients  75 yrs of age or older as a “class two” or “evolving” indication for 
coronary angioplasty.
CORONARY BYPASS SURGERY
Perioperative survival and long-term follow up following bypass surgery 
in elderly individuals are reported by several centers. In view of the fact that 
surgery is often reserved for older patients who have few other options, it is not 
surprising  that  perioperative  survival  is  lower,  and  complications  –including 
cognitive  dysfunction-higher  in  older  age  groups.  This  can  be  related  to 
increased  prevalences  of  left  main  disease,  left  ventricular  dysfunction,  and 
advanced coronary disease in older patients undergoing revascularization. It is 
also related to other associated diseases, most importantly, pulmonary and renal 
dysfunction.
Despite  a  higher  perioperative  mortality,  postdischarge  survival  is 
comparable to that in younger patients, and in the CASS registry report, surgical 
survival in patients over 65 yrs of age actually trended higher than survival in 
patients treated with medical therapy over a 6-yr follow up period.
ACUTE MYOCARDIAL INFARCTION
In the United States it is estimated that the elderly account for 60% of all  
deaths from acute myocardial infarction (AMI) and 10%of all patients with acute 
coronary  syndromes  (ACS).  Although  similar  data  is  not  available  in  our 
country, with improving life expectancy, there is no reason to believe that the 
situation will be substantially different.
Unique pathophysiological features of ageing make the elderly prone to 
atypical presentations of ACS and AMI. Symptoms of infarction in the elderly 
are more likely to include dyspnea and those related to decreased cardiac output, 
including mental status changes, rather than typical chest pain. Older individuals 
are also more likely to have an enzyme pattern consisting of an elevated MB 
fraction in the presence of a normal total Creatinine kinase (CK).
The highest risk group among patients with AMI is the elderly. In the 
GUSTO-I study the 30-day mortality in patients between 75 and 85 yrs of age 
was 6 times more, and in those over 85 yr, 10 times more than in patients under 
65 yr of age.
ISSUES IN DIAGNOSIS
 The most important consideration is the frequency of silent presentations 
and atypical syndromes.
 Unrecognised  myocardial  infarction  patients  are  more  likely  to  be 
hypertensive, have diabetes, and smoke, and have a lower prevalence of 
preceding angina.
 A related  issue  is  the  tendency  of  elderly  patients  to  present  later  to 
hospital. In an urban setting, Rajagopalan et al found that age >65 yrs 
independently predicted late presentation. This can be attributed to the 
presence of atypical symptoms.
 The initial ECG does not show typical ST elevation or Q waves in 40% of 
elderly patients and lower elevations in creatine kinase levels.
Therefore  a  high  index  of  suspicion  is  essential  for  early  diagnosis  and 
institution of early appropriate therapy.
MANAGEMENT
Treatment  of  acute  myocardial  infarction  in  the  elderly  should  be 
tempered by the knowledge that older individuals are several-fold more likely to 
suffer serious complications of infarct, including death, congestive heart failure, 
recurrent infarction, and rupture than their younger counterparts.
In the prethrombolytic era, the Multicenter Investigation of the Limitation 
of  Infarct  Size (MILIS)  study group reported that  65-74 yr old patients  with 
acute infarction have a  higher  frequency of congestive heart failure(44 versus 
28%) in hospital death(14 versus 7%) and    1 yr mortality for hospital survivors 
(19 versus 5%) than those less than 65 yrs of age. The most striking finding on 
autopsy was a marked age-related increased finding of  rupture.  Rupture  was 
present in over 80% of those older than 70 yrs of age who died and had autopsy 
examination. 
FIBRINOLYTIC THERAPY
The principal issue in management is that of reperfusion therapy. Elderly 
patients tend to present later to hospital and a substantial proportion of patients 
therefore  might  not  be  eligible  for  fibrinolytic  therapy  (FT).  Associated  co-
morbid conditions may result in relative contraindications to FT.  The risk of 
intracranial bleeding and other major haemorrhagic complications are higher in 
patients older than 75 yrs.
Nevertheless,  the  absolute  benefits  of  FT  in  this  population  is  more 
pronounced than in younger age groups, primarily because of the higher baseline 
risk imposed by increased age and the higher prevalence of multivessel disease 
and poor left ventricular systolic and diastolic function. The Thrombolysis in 
Myocardial  Infarction  (TIMI)-2  investigators  studied  the  impact  of  age  on 
outcomes and the influence of postlytic management strategies in older infarct 
patients.  They reported an increase in mortality,  complications,  and recurrent 
infarctions.  This  may  be  related  to  an  age-related  increase  in  delay  to  the 
administration of the thrombolytic, perhaps due to the increased likelihood of 
atypical  presentations  in  older  population,  and  to  the  fact  that  fewer  older 
individuals were eligible to receive concomitant ß-blocker therapy.
CHOICE OF FIBRINOLYTIC AGENTS
Despite  the  marginally  higher  stroke  rate  with  t-PA,  the  net  benefit 
compared to SK is more pronounced in the patients up to 85 yrs of age.
PRIMARY ANGIOPLASTY
Primary  angioplasty  has  been  consistently  associated  with  better 
outcomes and lower stroke rates than FT.
ADJUNCTIVE THERAPIES
ANTIPLATELET THERAPY
There is robust evidence suggesting that the absolute benefit of the use of 
aspirin in the management of AMI and ACS and in secondary prevention after 
these events is similar or greater in elderly than younger populations.
Clopidogrel use was associated with a 2% absolute reduction when added 
to aspirin in patients with ACS in CURE study.
The  glycoprotein  IIb/IIIa  inhibitors  have  generally  shown  equivalent 
benefits across all age groups although most trials did not specifically look at the 
elderly population. 
ANTITHROMBOTIC THERAPY
The elderly tend to have increased sensitivity to the anticoagulant effects 
of unfractioned heparin even after adjustment for body weight. Low-molecular –
weight heparins are increasingly used to treat ACS. The existing data does not 
suggest  any attenuation of benefit  with age attributable to increased bleeding 
risk.
POST INFARCTION MANAGEMENT
Post infarction risk stratification is based on the same factors as those in 
the  younger  patients,  that  is,  left  ventricular  function,  the  frequency  and 
complexity of ventricular arrhythmias, and subjective or objective evidence of 
recurrent ischemia. Of several factors assessed in a prognostic study, Killip class 
was the most powerful predictor of survival in those aged 65 or more. Those 
who are at increased risk because of poor left ventricular function may benefit 
from revascularization procedures with angioplasty or bypass surgery, if viable 
myocardium is dysfunctional due to low flow.
There is a large body of data to recommend the use of ramipril,  beta-
blockers and statins in patients older than 65 yrs of age. Larger absolute risk 
reductions  are  generally  seen  in  the  elderly.  Nevertheless,  the  use  of  these 
therapies in eligible elderly patients is under 50%.
If poor left ventricular function is due to extensive scar, ACE inhibitor 
therapy improves survival, decreases left ventricular filling pressures and cavity 
size, and improves exercise tolerance.
The reduction in fatal and nonfatal events following infarction in patients 
with  ejection  fractions  of  40%  or  less  in  the  Survival  and  Ventricular 
Enlargement trial (SAVE) was the same in those older and younger than65 yrs 
of age.
There is less to offer those judged to be at increased risk on the basis of 
post  infarction  arrhythmias.  The  inability  of  antiarrhythmics  to  decrease  the 
mortality  in  these  individuals  is  highlighted  by  the  data  from  the  Cardiac 
Arrhythmia Suppresion Trial, which indicated that the class IC agents encainide 
and flecainide were actually associated with an increase in cardiac mortality in 
patients over 60 yrs of age, in whom the risk ratio was four to five fold higher in 
the  treated,  as  compared  with  the  placebo  groups.  Some  reports  indicate 
amiodarone may improve survival.
Those who have recurrent ischemic symptoms, or who have a positive 
electrocardiogram on stress testing, are at increased risk of recurrent infarction 
or death over the ensuing year and are generally considered for more aggressive 
diagnostic evaluation, including cardiac catheterization,  in order to assess the 
suitability for revascularization procedures.  If individuals are judged to be at 
low risk, one aspirin a day may be effective prophylaxis. Older patients also 
benefit from the routine use of ß-blockers. Both the Norwegian Timolol study 
and  the  ß-blocker  Heart  Attack  (BHAT)  propanolol  study  demonstrated  a 
significant improvement in survival for those over 60-65 yrs of age in the ß-
blocker  as  compared  with  the  placebo  groups.  Finally,  an  extensive  trial  of 
continuing versus discontinuing anticoagulation following myocardial infarction 
in 878 patients over 60 yrs of age indicated that anticoagulation reduced the 2-yr 
incidence of recurrent infarction (from 15.9% in the placebo group to 5.7% in 
the treated group) and of total mortality (from13.4%in the placebo to 7.6% in the 
treated group) over a 2-yr follow-up period. This benefit was not outweighed by 
significant intracranial or extra cranial bleeding events.           
                          
MATERIALS AND METHODS
This  study  was  conducted  during  JUNE  2009  to  NOVEMBER  2009 
period.   60 consecutive patients of age 65 and above admitted to the coronary 
care unit with a diagnosis of acute STEMI were included in the study.
All  patients  included in the study were subjected to ECG examination 
with conventional 12 leads and in addition V3R, V4R, V7 to V9.  Rhythm strips 
were taken in patients with arrhythmia.
All patients were assessed clinically and electrocardiographically to make 
a diagnosis of STEMI.  Special emphasis made on presenting complaints, risk 
factor, comorbidities, vital signs, arrhythmias and mortality.  All patients were 
followed up till death or discharge.  Pre-discharge ECHO was done to assess the 
LV function.
Patients with age less than 65 and patients with NSTEMI, UA, Recurrent 
MI are excluded from the study.
 
OBSERVATION AND RESULTS
The observations in 60 elderly patients with acute STEMI (ST Elevation 
Myocardial  Infarction)  is  presented  in  this  section  in  descriptive  and tabular 
form.
AGE
Cases were divided into groups of 5 years difference for comparing age 
and sex incidence.
Incidence in male and female almost equal in the age group 65 – 74.  The 
incidence is increased in females in age group 75 and above.  The highest age 
was a female with 85 years old.
32 patients were females and 28 were males.
TABLE 1
AGE NO. OF 
PATIENTS
PERCENT MALE FEMALE
65 – 69 25 42% 14 11
70 – 74 17 28% 8 9
75 – 79 8 13% 3 5
80 – 84 9 15% 3 6
85 and above 1 2% 0 1

SEX DISTRIBUTION
47%
53%
MALE FEMALE
PRESENTING SYMPTOMS
CHEST PAIN
55 patients had complaints of retrosternal chest pain.  5 patients who did 
not have chest pain as presentation had dyspnoea as presenting complaint.
TABLE 2
PRESENTING SYMPTOMS
Sl.No SYMPTOMS NO. PERCENT
1 CHEST PAIN 55 92%
2 DYSPNOEA 29 48%
3 SWEATING 26 43%
4 PALPITATION 18 30%
5 VOMITING 10 15%
6 SYNCOPE 3 5%
7 WITHOUT CHEST PAIN 5 10%

RADIATION OF CHEST PAIN
Radiation of Chest Pain was noticed in 36 patients (60%).  Radiation to 
Left  Upper  limb was  seen  in  24  patients  (40%),  6  patients  had  radiation  to 
epigastrium (10%), another 3 patients (5%) had radiation to Right Upper Limb. 
Other site of radiation in 3 patients (5%). 
TABLE 3
RADIATION OF CHEST PAIN
S.No RADIATION SITE NO.OF PATIENTS PERCENT
1 LEFT UPPER LIMB 24 40%
2 EPIGASTRIUM 6 10%
3 RIGHT UPPER LIMB 3 5%
4 JAW, HEAD & NECK 3 5%

Duration of symptoms
The time duration from the onset of symptoms and patient reaching the 
hospital was noted.  Sixteen patients (26%) presented after 24 hours.  44 patients 
presented within 24 hours.  Among them, only 17 patients (29%) were able to 
reach the hospital within six hours.
TABLE 4
DURATION OF SYMPTOMS
TIME NO. OF PATIENTS PERCENT
0 – 6 hrs 17 29%
6 – 12 hrs 27 45%
More than 12 hrs 16 26%
TABLE 4
RISK FACTORS
VARIABLE NO. OF 
PATIENTS
PERCENT MALE FEMALE
SMOKING 20 33% 20 0
DIABETES MELLITUS 15 25% 8 7
HYPERTENSION 13 22% 5 8
ALCOHOL 12 20% 12 0
DYSLIPIDEMIA 3 5% 1 2
OBESITY 3 5% 1 2
NONE OF THE ABOVE 18 30% 3 15
Diabetes Mellitus
15  patients  (25%)  had  diabetes  and  all  of  them  were  on  oral 
hypoglycaemic agents.  An attempt was made to go through the earlier medical 
records wherever available.

Systemic Hypertension
Patients were considered to be hypertensive if they had been told to have 
hypertension earlier by a doctor and put on antihypertensive drugs or serial BP 
recordings  in  hospital  were  consistently  high.   13  patients  had  hypertension 
(22%).
Smoking
Out of 28 males, 20 were smokers.  None of the female patients were 
smokers.  All the smokers were smoking 10 – 20 beedies/cigarettes per day for 
atleast 10 years.  60% of them were current smokers.
Alcohol
Out of 28 male, 12 were in habit of consuming alcohol.  None of the 
female patients were in the habit of consuming alcohol.
Dyslepidemia
3 patients were found to have dyslipidemia which was detected on routine 
check up elsewhere.  None of them were on lipid lowering agents.
Obesity
3 patients (5%) were found to be obese.  Body Mass Index was calculated 
for all patients.
CLINICAL PRESENTATION
3 patients (5%) had bradycardia.   Tachycardia was seen in 18 patients 
(30%).   Hypotension  was  noticed  in  6  patients  (10%).   Tachypnoea  was 
observed in 24 patients (40%).  12 patients (20%) had raised JVP.  Third or 
fourth heart sound were detected in 10 patients (15%).
TABLE 5
CLINICAL PRESENTATION
CLINICAL SIGN NO. OF PATIENTS PERCENT
PULSE <60 3 5%
PULSE >100 18 30%
BP <100 6 10%
RR >18 24 40%
↑ JVP 12 20%
S3 / S4 10 15%

KILLIPS CLASS
Patients were assigned to Killips class depending on the signs of heart 
failure at the time of presentation.
 Class I - No heart failure
 Class II - Mild to moderate heart failure. 
                                       (Presence of S3, Rales at the base or 
                                       rales not exceeding half of the chest)
 Class III - Severe heart failure(pulmonary edema)
 Class IV - Cardiogenic shock
35 patients (58%) presented in Killips class I.  13 patients (22%) were in 
Killips Class II.  Class III and Class IV each consisting 6 patients (10%).
TABLE 6
KILLIPS CLASS
CLASS NO. OF 
PATIENTS 
PERCENT
I 35 58%
II 13 22%
III 6 10%
IV 6 10%

ECG Patten
ECG evidence of Inferior Wall MI was observed in 24 patients (40%). 
Anteroseptal MI was noted in 18 patients (30%).  Extensive Anterior wall MI 
was observed in 16 patients (27%).  Other patterns were observed in 2 patients 
(3%).
 TABLE 7
ECG PATTERN
Sl.No. PATTERN OF MI
NO. OF 
PATIENTS PERCENT
1 IW MI 24 40%
2 AS MI 18 30%
3 AW MI 16 27%
4 OTHERS 2 3%

ARRYTHMIAS
RBBB was  observed in  12  patients  (20%).   LBBB was  noted  in  one 
patient.  Bifascular block (RBBB + LAFB) was seen in 3 patients (5%).
First  degree AV block seen in 3 patients (5%).  Complete heart  block 
developed in 3 patients (5%).
Ventricular  premature  beats  were  observed  in  3  patients  (5%). 
Ventricular  Tachycardia  or  Ventricular  fibrillation  occurred  in  nine  patients 
(15%).  Atrial fibrillation was present in two patients (3%).
TABLE 8
Sl.No. ARRYTHMIA
NO. OF 
PATIENTS PERCENT
1 RBBB 12 20%
2 LBBB 1 2%
3 RBBB + LAFB 2 3%
4 1° AV BLOCK 3 5%
5 COMPLETE HEART BLOCK 3 5%
6 VENTRICULAR PREMATURE BEATS 3 5%
7 VENTRICULAR TACHYCARDIA OR 
VENTRICULAR FIBRILLATION
9 15%
8 ATRIAL FIBRILLATION 2 3%

MORTALITY
Out of  total  60 patients,  15 patients  (25%) expired in the hospital.   8 
patients were female and 7 were male.  7 patients were of age 65 – 74.  8 patients 
were of age 75 and above.
TABLE 9
AGE AND SEX DISTRIBUTION OF DEATHS
AGE MALE FEMALE TOTAL
65 – 74 4 3 7
75 & Above 3 5 8
Total 7 8 15

TABLE 10
AGE AND MORTALITY
AGE
NO. OF PATIENTS MORTALITY 
IN PERCENTTOTAL DEATHS
65 – 74 42 7 16%
75 & Above 18 8 44%
TABLE 11
KILLIPS CLASS & MORTALITY
CLASS NO. OF 
PATIENTS
DEATHS MORTALITY 
IN PERCENT
I 35 2 6%
II 13 4 30%
III 6 3 50%
IV 6 6 100%
DISCHARGE
45 out of 60 patients were discharged.  Pre discharge ECHO was done to 
assess LV systolic function.  32 patients (71%) showed mild-to-moderate LV 
dysfunction.  2 patients (5%) showed severe LV dysfunction.  11 patients (24%) 
showed near normal LV function.
TABLE 12
LVEF AT DISCHARGE
Sl.No. LVEF NO. OF PATIENTS PERCENT
1 50% and above 11 24%
2 35 – 49 32 71%
3 <35 2 5%

DISCUSSION
Sixty proven cases of Acute ST Elevation Myocardial infarction of Age 
65  and  above  were  selected  for  analysing  the  various  risk  factors,  clinical 
features and complications.  All patients were subjected to ECG examination of 
conventional 12 leads, V3R V4 R and V7V8V9 and rhythm strip wherever needed.
On analysing the incidence, it was found that STEMI in elderly is slightly 
more in females.  53% were females and 47% were males.  It is a contrast with 
the middle age where MI is more common in males.
92%  of  patients  presented  with  chest  pain.   All  of  them had  typical 
retrosternal chest pain.  All the patients had chest pain lasting for more than 30 
minutes.  Most of the patients developed chest pain while at rest.
When analysing symptoms other than chest pain, Dyspnoea is observed in 
48% of patients.  This points out the fact that elderly tend to have more dyspnoea 
than the younger for the given compromised cardiovascular status.
Patients presented without chest pain were around 10%.  These patients 
had  either  dyspnoea  or  syncope.   These  kinds  of  observations  were  well 
recognised.  In the Framingham study, atypical presentation is around 30% in 
male aged 75 – 84 years compared with only 5% in men aged 45 – 54.
On analysing the duration of symptoms, i.e. the time taken from the start 
of symptoms and to reach the hospital, only 74% reached the hospital within 12 
hrs.  This is the window period where thrombolysis is effective and myocardium 
could  be  salvaged.   26%  of  patients  presented  late  and  not  eligible  for 
thrombolytic therapy.  Rajagopalan et al in his study found that age >65 years 
independently predicted late presentation.
On  analysing  the  risk  factors  for  MI,  smoking  (33%)  was  the  most 
common and exclusively in males.  None of the females were smokers.
In common to both males and females, diabetes is the leading risk factor 
which was observed in 25%.  Hypertension and dyslipidemia were observed in 
13% and 5% respectively.  All Dyslipidemics were found to be coexisting with 
diabetes.
Obesity is not observed significantly.  It was around 5%.
Hector  Beuno  et  al  in  his  studies  had  analysed  the  incidence  of  risk 
factors.  He had found hypertension in 45%, Diabetes Mellitus in 23%, smoking 
in 63%, obesity in 22%, Dyslepidemia in25%.  
On  analysing  the  clinical  presentation,  most  observed  signs  were 
Tachypnea and Tachycardia, 40% and 30% respectively.  35% of patients had no 
evidence of heart  failure i.e.  Killips  Class I.   22% of patients  had creps not 
exceeding half of chest i.e. Killips Class II.  10% were having extensive rales 
and  elevated  JVP  i.e.  Killips  Class  III.   Another  10%  of  patients  were  in 
Cardiogenic shock i.e. Killips Class IV.
This shows that  the elderly tend to present higher Killips class (20%) 
which  significantly  predicts  the  higher  morbidity  and  mortality  they  tend  to 
develop.
On analysing the pattern of MI, the inferior wall myocardial infarction 
was the most common (40%) followed by Anteroseptal MI and Anterior Wall 
MI 18% and 16% respectively.  Other patterns were observed in 3%.
On analysing the IWMI, 25% associated with posterior wall involvement 
and 33% associated with right ventricular involvement.  Chockalingam et al in 
his study revealed RVMI was seen in one third of acute IWMI.
The significant percentage of AWMI i.e. 27% reveals that higher degree 
of CAD.  In a contemporary clinical trial data base patients above 80 years who 
underwent angiography had a 72% prevalence of multivessel disease as against 
33% in patients less than 65 years of age.
On looking into the treatment, 64% received thrombolytic therapy, 36% 
had not received.  Analysing the reasons for not thrombolysed, most of them i.e. 
16 out of 22 patients presented late.  Another 6 patients were in hypotension.
On follow up,  arrhythmic  complications  were  observed in  45%.   The 
most commonly observed arrhythmia was RBBB (20%),  followed by VT/VF 
(15%).
Bifasicular  block  was  observed  in  5%  and  complete  heart  block  was 
around 5%.  All patients who developed complete heart block were treated with 
temporary pacing.  Reported incidence for CHB by Pillip Podrid et al is around 
8%. 
Atrial fibrillation was observed in only 2 patients.  Among the two, one 
had coexisting RHD (3%).  Peter Berger et al in his studies of complication of 
Acute  Myocardial  Infarction found atrial  fibrillation  in  10% of patients  with 
IWMI.
On analysing the deaths, the mortality is high around 25%.  Most of the 
deaths happened in Killips Class III, Class IV and age >75.
GUSTO I Trial clearly established that the old age is the independent risk 
factor for high mortality (31.2%).
45 out of 60 patients were discharged from the hospital.  Among them 11 
patients (24%) showed near normal LV function (EF >50%).  32 patients (71%) 
showed mild  to  moderate  LV dysfunction  (EF 35 –  49%).   2  patients  (5%) 
showed severe LV dysfunction (EF <35%).
Among the discharged, 34 patients (76%) left with underlying morbidity 
in the form of LV dysfunction.  They have to be evaluated for further risks of 
coronary  events  and  to  be  followed  up  with  medical  management  and 
revascularisation, if indicated.
CONCLUSION
1. The incidence of STEMI in elderly 65 years and above is more common 
in females, the difference being high as the age advances.
2. Even  though  chest  pain  is  the  most  common  presentation,  atypical 
presentation without chest pain is also high (10%).
3. Delayed presentation is common (26%).
4. Tachypnea and Tachycardia are the most commonly observed signs.
5. Smoking is  the most common risk factor  (33%) followed by Diabetes 
Mellitus (25%).  Patients without any conventional risk factors were 30%.
6. Higher Killips class is common (20%).
7. The most common pattern is IWMI (40%).
8. Significant number of patients (36%) were not thrombolysed.
9. Mortality is high (25%).  Mortality is higher in females than males and is 
higher in age >75 than age <75.
10. Post infarction morbidity in the form of LV dysfunction is high (76%).
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ANNEXURE
 PROFORMA
 MASTER CHART
 ETHICAL COMMITTEE  APPROVAL 
ORDER
 ABBREVIATIONS
PROFORMA
Name : Age : Sex :
Address : Height : Weight : BMI : 
Clinical presentation:
Duration of symptoms:
Hypertension: Diabetes: Hyperlipidemia :
Family history of IHD:
Previous MI:
Other co-morbidities:
Smoking: Alcohol: Diet:
General Examination
Conscious Level:
Orientation:
PR: BP: RR: JVP:
Anaemia:
Cyanosis:
Clubbing:
Icterus:
Pedal Edema:
CVS
Heart sounds: Murmurs: Rub:
RS
Air entry: Crackles / Wheeze:
P/A
CNS
INVESTIGATIONS
1. Urine R/E: Albumin: Sugar: Deposits:
2. CBC:
 TC:
 DC:
 ESR:
 Hb:
 PLC:
3. RBS
4. Urea
5. Creatinine
6. Electrolytes
7. Chest PA view
8. ECG
9. ECHO
TREATMENT
 Thrombolysis
 PCI
 None
COMPLICATIONS
 Reinfarction
 Arrythmias
 Hypotension
 Acute MR
 CCF
 Cardiogenic shock
 Others
 Death 
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1 Kokila 68 F 02.06.09 + + + - - - - 8 hrs - - - - - - - 90 100/70 16 - -
2 Sundaraj 65 M 04.06.09 + - - + - - - 9 hrs - - - - + - -
10
0 110/80 20 - -
3 Chockalingam 67 M 06.06.09 + + + + + - - 4 hrs - - - - + + -
12
4 80/60 40 + +
4 Hayath Basha 72 M 06.06.09 + + - - - - - 6 hrs - - - - + - - 90 110/80 14 - -
5 Daisy 65 F 07.06.09 + - - - + + - 8 hrs - - - - - - - 98 130/80 16 - -
6 Ammaayeeammal 70 F 18.06.09 - - - + + + - 3 hrs - - - - - - -
12
6 80/50 32 + +
7 Mohanavel 67 M 20.06.09 + + - - - - -
10 
hrs + - - - + - - 90 130/80 14 - -
8 Abdul Azeez 67 M 27.06.09 + - + - - - -
1 
week - - - - - + - 70 100/80 18 - -
9 Sakunthala 68 F 29.06.09 + + + + - - -
11 
hrs - - - - - - -
11
6 110/80 26 - -
10 Alamelu 82 F 30.06.09 + - - - - - - 6 hrs - - - - - - - 98 110/80 14 - -
11 Raman 68 M 30.06.09 + + + - + - - 3 hrs - - - - + + - 50 130/70 18 - -
12 Kannamal 70 F 04.07.09 + - + - - - -
12 
hrs - - - - - - -
12
0 160/90 16 - -
13 Leela 65 F 07.07.09 + - + - + - - 6 hrs + - + + - - -
13
0 90/60 30 + +
14 Puratchimani 68 F 08.07.09 + + + - - + - 5 hrs + + - - - - - 78 160/100 24 - -
15 Dharma 70 M 09.07.09 + + + + + - - 4 hrs - + - - + - -
10
8 140/90 30 - -
16 Shanthakumar 73 F 15.07.09 + - + + + - -
16 
hrs - + - - - - - 90 160/100 20 - -
17 Ekambaram 67 M 21.07.09 + + - + - - - 4 hrs - - - - - - -
11
8 130/80 24 - +
18 Ramamoorthy 65 M 21.07.09 + + - - - - - 8 hrs + - - - + + - 80 110/80 14 - -
19 Ramasamy 82 M 23.07.09 + + - - - - -
2 
days - - - - + - - 68 130/80 18 - -
20 Natarajan 75 M 26.07.09 + + - - - - -
4 
days - - - - + - - 60 90/60 18 - -
21 Mangalalakshmi 80 F 01.08.09 + + + + - + - 8 hrs - - - - - - -
12
4 130/80 20 - +
22 Mariyam Beevi 70 F 03.08.09 + + - + - - - 4 hrs - - - - - - - 60 100/60 20 - -
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1 - I AWMI + - - - - 45% -
2 + II AWMI + - - - RBBB 40% -
3 + IV AWMI - + + + VT - +
4 - I ASMI + - - - - 45% -
5 - I ASMI + - - - - 50% -
6 + IV IW/PW/RVMI - + + + VT/VF - +
7 - I IWMI/PWMI + - - - - 50% -
8 - I ASMI - - - - Bifasicular Block 40% -
9 + II ASMI + - + - - 40% -
10 - I IWMI + - - - - 50% -
11 - I IWMI + - - - AF 55% -
12 + III AWMI + - + - VPB 35% -
13 + IV ASMI - + + + - - +
14 - I IWMI/PWMI + - - - 1° AV BLOCK 45% -
15 + II AWMI + + + + VF - +
16 - I ASMI - - - - RBBB + LAFB 40% -
17 - III AWMI + - + - - 35% -
18 - I IWMI + - - - RBBB 45% -
19 - I IWMI - - - - RBBB 45% -
20 + II IWMI/RVMI - + - - VF - +
21 + II AWMI + + + + VF - +
22 + II IW/PWMI + - - -
RBBB/SINUS 
BRADYCARDIA 45% -
23 Sivanathan
7
0 M
04.08.0
9 + - + - - - - 2 hrs - - - - - - - 68 130/80
2
1 - -
24 Rajendrababu
6
8 M
08.08.0
9 + + - - - - - 2 hrs - - - - + + - 72 130/80
1
8 - -
25 Antony
7
3 M
10.08.0
9 + + + + - - - 4 hrs - - - - + + - 90 100/70
2
0 - -
26 Muniammal
6
7 F
11.08.0
9 + + - + - + + 8 hrs - - - - - - - 34 90/70
2
6 - -
27 Thirumurugan
8
0 M
18.08.0
9 + - + + - - -
3 
days - - - - + + COPD 76 140/90
2
8 - -
28 Swaminathan
6
5 M
21.08.0
9 + - + + + - - 8 hrs + + - + - - - 98 110/80
3
0 + +
29 Saleem
6
8 M
29.08.0
9 + - + + - - - 2 hrs - - - - + + - 88 150/90
2
6 - -
30 Thangaiah
6
8 M
01.09.0
9 + + + + - - -
10 
hrs + - - - - - - 90 130/80
1
6 - -
31 Rajammal
7
0 F
02.09.0
9 + + - - - + - 8 hrs - - - - - - - 68 110/80
1
8 - -
32 Kasi
6
5 M
03.09.0
9 + + - - -  - 4 hrs + + - - + + CVA 70 120/80
1
6 - -
33 Saraswathy
7
5 F
05.09.0
9 + - - + - + -
10 
hrs + + - + - - - 80 130/80
2
0 - -
34 Kesavan
7
6 M
07.09.0
9 + + + + + - - 6 hrs - - - - + + - 110 110/70
2
4 + -
35 Mehreinsha
6
5 F
07.09.0
9 +  + + + - -
12 
hrs - - - - - - - 98 100/70
1
8 - -
36 Chellammal
6
5 F
07.09.0
9 + + - - - + - 4 hrs - - - - - - - 104 110/70
1
4 - -
37 Lakshmi
7
4 F
10.09.0
9 - - + + + - - 2 hrs - - - - - - RHD 118 130/100
3
0 + +
38 Valliammal
8
0 F
11.09.0
9 - - + + + - - 1 hr - - - - - - - 70 80/60
4
0 + +
39 Munusamy
7
0 M
13.09.0
9 + + - - - - - 6 hrs + - - - + + - 80 130/80
1
4 - -
40 Selvam
8
4 M
19.09.0
9 + - + - - - - 8 hrs - - - - - - - 60 130/80
1
6 - -
41 Masanam
6
5 F
22.09.0
9 + - + + - - -
16 
hrs - - - - - - - 98 110/70
1
6 - -
42 Nallammal
7
5 F
24.09.0
9 + - - + + - -
24 
hrs + + - - - - - 110 108/80
1
8 - -
43 Angammal
7
5 F
25.09.0
9 - - - + + - + 6 hrs - - - - - - - 116 90/60
3
2 + +
44 Muthusamy
7
2 M
02.10.0
9 + + - - - - - 8 hrs + + - - + - - 70 110/70
1
4 - -
45 Babu
6
5 M
03.10.0
9 + + - - - - - 4 hrs + + - - - - CKD 62 100/70
1
6 - -
7 05.10.0 1
2
3 - I IWMI + - - - - 50% -
2
4 - I ASMI + - - - - 45% -
2
5 - I IW/PWMI + - - - VT 46% -
2
6 + II IW/PWMI + - - - HIGH GRADE AV BLOCK 40% -
2
7 + II AWMI - - + - RBBB 30% -
2
8 + II
AWMI + 
IWMI + - + - VT/VF - +
2
9 + II AWMI + - - - - 55% -
3
0 - I ASMI + - - - RBBB/VPB 40% -
3
1 - I IWMI/RVMI + - - - - 50% -
3
2 - I IWMI/FWMI + - - - RBBB 45% -
3
3 - I IWMI + - - - - 50% -
3
4 + III ASMI + + + + - - +
3
5 + II ASMI + - + - VPB 40% -
3
6 - I ALMI + - - - - 45% -
3
7 + III ASMI + - - - RESISTANT VF - +
3
8 + IV AWMI - + + + CRBBB - +
3
9 - I ASMI - - - - Bifasicular Block 40% -
4
0 - I IWMI/RVMI + - - - 1° AV BLOCK 50% -
4
1 - I ASMI - - - - COMPLETE HEART BLOCK 35% -
4
2 - I ASMI - - - - - 40% -
4
3 + IV AWMI - + + + - - +
4
4 - I IWMI/RVMI + - - - RBBB 50% -
4
5 - I IWMI/RVMI + - - - RBBB 46% -
4
6 - I IWMI + - - - - 50% -
4
7 + III AWMI - - + - VPB 30% -
48 Jagadhambal
8
0 F
15.10.0
9 + + - - + - - 6 hrs - - - - - - - 110 110/80
1
4 - -
49 Jeyalakshmi
7
0 F
17.10.0
9 + - - + - - - 8 hrs - - - - - - - 68 110/80
2
4 + -
50 Andal
7
0 F
20.10.0
9 + + - - - - -
16 
hrs - - - - - - - 98 130/70
1
4 - -
51 Natarajan
7
2 M
24.10.0
9 + + - - - + +
24 
hrs + + - - - - - 60 100/70
1
4 - -
52 Sundarammal
7
5 F
26.10.0
9 + - - + - - - 6 hrs - - - - - - - 68 130/80
1
6 - -
53 Poongavanam
8
4 F
27.10.0
9 + + + - - + - 8 hrs - - - - - - - 70 110/80
1
8 - -
54 Kathammal
8
5 F
31.10.0
9 - - - + + - -
12 
hrs - + - - - - - 110 130/80
2
0 + +
55 Chellammal
6
7 F
01.11.0
9 + + + - - - - 6 hrs + + - - - - - 100 120/80
2
2 - -
56 Begambevi
7
8 F
04.11.0
9 + + - - - + -
14 
hrs - - - - - - - 80 130/80
1
4 - -
57 Ismail
6
7 M
07.11.0
9 + + - - - - - 8 hrs - - - - + + - 96 140/80
1
8 - -
58 Rajasekar
7
5 M
11.11.0
9 - - - + + - -
14 
hrs - - - - + - - 116 100/70
4
0 + +
59 Kamakshi
6
5 F
12.11.0
9 + + + - + - -
2 
days - - - - - - - 64 110/80
2
8 - -
60 Killiammal
8
0 F
13.11.0
9 + + - - - - -
24 
hrs - + - - - - - 82 140/90
1
8 - -
4 - I ASMI - - - - - 40% -
8
4
9 + II IW/RV/PWMI + - - - COMPLETE HEART BLOCK 45% -
5
0 - I ASMI - - - - - 40% -
5
1 - I IWMI - + - - 1° AV BLOCK 45% -
5
2 - I IWMI + - - - RBBB 50% -
5
3 - I IWMI/RVMI + + + + - - +
5
4 + III AWMI - + + + - - +
5
5 + II AWMI + - - - - 40% -
5
6 - I ASMI - - - - - 40% -
5
7 - I ASMI + - + - VF - +
5
8 + IV AWMI - + + + - - +
5
9 - I IWMI - - - - - 45% -
6
0 - I ASMI - - - - VPB 35% -
ABBREVIATIONS
ACE : Angiotensin Converting Enzyme
ACS : Acute Coronary Syndrome
AMI : Acute Myocardial Infarction
ASMI : Antero Septal Myocardial Infarction
AWMI : Anterior Wall Myocardial Infarction
ALMI : Antero Lateral Myocardial Infarction
AV Block : Atrioventricular Block 
BHAT : Beta Blocker Heart Attack
BP : Blood Pressure
CAD : Coronary Artery Disease
CASS : Coronary Artery Surgery Study
CHB : Complete Heart Block
CK : Creatine Kinase
CURE study : Clopidogrel in Unstable Angina to prevent Recurrent 
ischemic Events study
ECG : Electrocardiogram
ECHO : Echocardiogram
FT : Fibrinolytic Therapy
GUSTO Trial: Global Utilisation of Streptokinase and Tissue Plasminogen 
activator for occluded Coronary Arteries trial
HDL : High Density Lipoprotein
HMG CoA : Hydroxy Methylglutaryl Coenzyme A 
IWMI : Inferior Wall Myocardial
JVP : Jugular Venous Pulse
LAFB : Left Anterior Fascicular Block
LBBB : Left Bundle Branch Block
LV : Left Ventricle 
LVEF : Left Ventricular Ejection Fraction
MI : Myocardial Infarction
MILIS : Multicenter Investigation of the Limitation of Infarct size
NSTEMI : Non ST Elevation Myocardial Infarction 
RBBB : Right Bundle Branch Block
RHD : Rheumatic Heart Disease
SK : Strepto Kinase
SAVE : Survival and Ventricular Enlargement 
STEMI : ST Elevation Myocardial Infarction
TIMI : Thrombolysis in Myocardial Infarction
t-PA : tissue Plasminogen Activator 
UA : Unstable Angina
VPB : Ventricular Premature Beat
VT : Ventricular Tachycardia
VF : Ventricular Fibrillation 
